317 related articles for article (PubMed ID: 22594639)
1. Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.
Wan HL; Wang ZR; Li LL; Cheng C; Ji P; Liu JJ; Zhang H; Zou J; Yang SY
Chem Biol Drug Des; 2012 Sep; 80(3):366-73. PubMed ID: 22594639
[TBL] [Abstract][Full Text] [Related]
2. Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.
Qing XY; Zhang CH; Li LL; Ji P; Ma S; Wan HL; Wang ZR; Zou J; Yang SY
J Biomol Struct Dyn; 2013; 31(2):215-23. PubMed ID: 22831459
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
Ren JX; Li LL; Zheng RL; Xie HZ; Cao ZX; Feng S; Pan YL; Chen X; Wei YQ; Yang SY
J Chem Inf Model; 2011 Jun; 51(6):1364-75. PubMed ID: 21618971
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors.
Xie HZ; Liu LY; Ren JX; Zhou JP; Zheng RL; Li LL; Yang SY
J Biomol Struct Dyn; 2011 Aug; 29(1):165-79. PubMed ID: 21696232
[TBL] [Abstract][Full Text] [Related]
5. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
Di-wu L; Li LL; Wang WJ; Xie HZ; Yang J; Zhang CH; Huang Q; Zhong L; Feng S; Yang SY
J Mol Graph Model; 2012 Jun; 36():42-7. PubMed ID: 22516037
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel mGluR1 antagonists: a multistep virtual screening approach based on an SVM model and a pharmacophore hypothesis significantly increases the hit rate and enrichment factor.
Li GB; Yang LL; Feng S; Zhou JP; Huang Q; Xie HZ; Li LL; Yang SY
Bioorg Med Chem Lett; 2011 Mar; 21(6):1736-40. PubMed ID: 21316965
[TBL] [Abstract][Full Text] [Related]
7. Combined SVM-based and docking-based virtual screening for retrieving novel inhibitors of c-Met.
Xie QQ; Zhong L; Pan YL; Wang XY; Zhou JP; Di-Wu L; Huang Q; Wang YL; Yang LL; Xie HZ; Yang SY
Eur J Med Chem; 2011 Sep; 46(9):3675-80. PubMed ID: 21641696
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
Sharma A; Thelma BK
J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
[TBL] [Abstract][Full Text] [Related]
9. Effective virtual screening strategy focusing on the identification of novel Bruton's tyrosine kinase inhibitors.
Xiao J; Zhang S; Luo M; Zou Y; Zhang Y; Lai Y
J Mol Graph Model; 2015 Jul; 60():142-54. PubMed ID: 26043662
[TBL] [Abstract][Full Text] [Related]
10. A three-dimensional pharmacophore modelling of ITK inhibitors and virtual screening for novel inhibitors.
Bagga V; Silakari O; Ghorela VS; Bahia MS; Rambabu G; Sarma J
SAR QSAR Environ Res; 2011 Mar; 22(1-2):171-90. PubMed ID: 21391146
[TBL] [Abstract][Full Text] [Related]
11. Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.
Bavi R; Kumar R; Choi L; Woo Lee K
PLoS One; 2016; 11(1):e0147190. PubMed ID: 26784025
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.
Wu F; Xu T; He G; Ouyang L; Han B; Peng C; Song X; Xiang M
Int J Mol Sci; 2012 Nov; 13(12):15668-78. PubMed ID: 23443087
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.
Xie HZ; Li LL; Ren JX; Zou J; Yang L; Wei YQ; Yang SY
Bioorg Med Chem Lett; 2009 Apr; 19(7):1944-9. PubMed ID: 19254842
[TBL] [Abstract][Full Text] [Related]
14. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Chem Biol Drug Des; 2007 Mar; 69(3):204-11. PubMed ID: 17441906
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines.
Ma XH; Wang R; Tan CY; Jiang YY; Lu T; Rao HB; Li XY; Go ML; Low BC; Chen YZ
Mol Pharm; 2010 Oct; 7(5):1545-60. PubMed ID: 20712327
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
[TBL] [Abstract][Full Text] [Related]
17. Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.
Pan Z; Scheerens H; Li SJ; Schultz BE; Sprengeler PA; Burrill LC; Mendonca RV; Sweeney MD; Scott KC; Grothaus PG; Jeffery DA; Spoerke JM; Honigberg LA; Young PR; Dalrymple SA; Palmer JT
ChemMedChem; 2007 Jan; 2(1):58-61. PubMed ID: 17154430
[No Abstract] [Full Text] [Related]
18. Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.
Shih KC; Shiau CW; Chen TS; Ko CH; Lin CL; Lin CY; Hwang CS; Tang CY; Chen WR; Huang JW
Bioorg Med Chem Lett; 2011 Aug; 21(15):4490-7. PubMed ID: 21724393
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors.
Elsayed MS; El-Araby ME; Serya RT; Abouzid KA
Arzneimittelforschung; 2012 Dec; 62(12):554-60. PubMed ID: 23023518
[TBL] [Abstract][Full Text] [Related]
20. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
